Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer

NCT00288249 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms
Breast Cancer, Metastatic

Interventions

DRUG: Sagopilone (BAY86-5302, ZK 219477)
DRUG: Sagopilone (BAY86-5302, ZK 219477)
DRUG: Sagopilone (BAY86-5302, ZK 219477)
DRUG: Sagopilone (BAY86-5302, ZK 219477)

Sponsor

Bayer